Effect of Intrauterine Administration of Autologous PBMC Modulated With IFNt on IVF Outcome
Recruiting
N/A
Interventional Study
Infertility, Female
IVF
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 50
- Sex
- Female
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 300 (estimated)
- Sponsor
- Nadezhda Women's Health Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to test the effect of modulated specialised immune cells isolated from the patients' own blood when administered to the uterus before embryo transfer on the IVF outcome (implantation, pregnancy and live birth rates).
To achieve this, blood will be obtained from eligible participants. Target cells will be isolated and incubated with the tested modulator for 24h, …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Participating in Assisted Reproduction Treatment
* Having primary infertility
* Having regular menstrual cycles
* Scheduled to undergo embryo transfer of euploid embryos only
Exclusion Criteria:
* Uterine pathologies
* Endometrial bacterial infections
* Active endometrial in…
Contacts